Publications by employees of eXcorLab GmbH:
2021 - today
Publications
• Krieter DH, Rüth M, Lemke HD, Wanner C.
Clinical performance comparison of two medium cut-off dialyzers.
Ther Apher Dial. 2023 Apr;27(2):284-292. doi: 10.1111/1744-9987.13919. Epub 2022 Aug 16. PMID: 36858049
• Krieter DH, Wanner C.
Comparison of four medium cut-off dialyzers.
Clin Kidney J. 2023 Feb 5;16(5):879-880. doi: 10.1093/ckj/sfad002. PMID: 37151420; PMCID: PMC10157749.• Krieter DH, Jeyaseelan J, Rüth M, Lemke HD, Wanner C, Drechsler C.
Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and
ethylene-vinyl alcohol copolymer membranes.
Artif Organs. 2021 Sep;45(9):1104-1113. doi: 10.1111/aor.13944. Epub 2021 May 4. PMID: 33617653.
• Hessler S, Rüth M, Lemke HD, Schmauss B, Hellmann R.
Deep UV Formation of Long-Term Stable Optical Bragg Gratings in Epoxy Waveguides and Their
Biomedical Sensing Potentials.
Sensors (Basel). 2021 Jun 3;21(11):3868. doi: 10.3390/s21113868. PMID: 34205166; PMCID: PMC8199964.
2019/2020
• Geremia I, Pavlenko D, Maksymow K, Rüth M, Lemke HD, Stamatialis D.
Ex vivo evaluation of the blood compatibility of mixed matrix haemodialysis membranes.
Acta Biomater. 2020 Jul 15;111:118-128. doi: 10.1016/j.actbio.2020.05.016. Epub 2020 May 21. PMID: 32447066.• Buckberry C, Hoenich N, Krieter D, Lemke HD, Rüth M, Milad JE.
Enhancement of solute clearance using pulsatile push-pull dialysate flow for the Quanta SC+: A
novel clinic-to-home haemodialysis system.
PLoS One. 2020 Mar 2;15(3):e0229233.
• Krieter DH, Kerwagen S, Rüth M, Lemke HD, Wanner C.
Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over
Time.
Toxins (Basel). 2019 Jan 16;11(1). pii: E47. doi: 10.3390/toxins11010047. PubMed PMID: 30654454• Leypoldt JK, Storr M, Agar BU, Boschetti-de-Fierro A, Bernardo AA, Kirsch AH, Rosenkranz AR, Krieter
DH, Krause B.
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.
Nephrol Dial Transplant. 2019 May 1;34(5):870-877. doi: 10.1093/ndt/gfy304. PubMed PMID: 30307514.
2017/2018
• Piatek T, Giebultowicz J, Rüth M, Lemke HD, Bonn F, Wroczynski P, Hrenczuk M, Malkowski P, Rozga J.
Albumin Apheresis for Artificial Liver Support: In Vitro Testing of a Novel Filter.
Ther Apher Dial. 2018 May 16. PubMed PMID: 29768707.• Trautmann A; Rüth M, Lemke HD., Walther T., Hellmann R.
Two-photon polymerization based large scaffolds for adhesion and proliferation studies of human primary
fibroblasts.
Optics and Laser Technology, Volume 106, 2018, 474–480• Krieter DH, Lange F, Lemke HD, Bonn F, Wanner C. Characterization of Fractionation Membranes in an
Animal Model of Double Filtration Lipoprotein Apheresis.
Ther Apher Dial. 2018 Jan 9. PMID:29316258
• Leypoldt JK, Storr M, Agar BU, Boschetti-de-Fierro A, Bernardo AA, Kirsch AH, Rosenkranz AR, Krieter
DH, Krause B.
Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.
Nephrol Dial Transplant. 2018 Oct 10. PMID: 30307514.
• Kirsch AH, Rosenkranz AR, Lyko R, Krieter DH.
Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
Contrib Nephrol. 2017;191:158-167. doi: 10.1159/000479264. Epub 2017 Sep 14. PMID: 28910799.
• Krieter DH, Devine E, Körner T, Rüth M, Wanner C, Raine M, Jankowski J, Lemke HD.
Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal.
Acta Physiol (Oxf). 2017 Feb;219(2):510-520. PMID: 272594632016
Publications
• Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, Schneider A, Wanner C, Rosenkranz AR,
Krieter DH.
Performance of hemodialysis with novel medium cut-off dialyzers.
Nephrol Dial Transplant. 2016 Sep 1. pii: gfw310.PubMed PMID: 27587605• Hessler S, Rüth M, Sauvant C, Lemke HD, Schmauss B, Hellmann R.
Hemocompatibility of EpoCore/EpoClad photoresists on COC substrate for optofluidic integrated Bragg
sensors.
Sensors and Actuators 2016.B 239, 916-922• Chevtchik NV, Fedecostante M, Jansen J, Mihajlovic M, Wilmer M, Rüth M, Masereeuw R, Stamatialis D.
Upscaling of a living membrane for bioartificial kidney device.
Eur J Pharmacol. 2016 Jul 6. pii: S0014-2999(16)30439-3
• Kumar RK, Basu S, Lemke HD, Jankowski J, Kratz K, Lendlein A, Tetali SD.
Influence of nanoporous poly(ether imide) particle extracts on human aortic endothelial cells (HAECs).
Clin Hemorheol Microcirc. 2016;64(4):931-940.
• Kumar RK, Basu S, Lemke HD, Jankowski J, Kratz K, Lendlein A, Tetali SD.
Effect of extracts of poly(ether imide) microparticles on cytotoxicity, ROS generation and proinflammatory
effects on human monocytic (THP-1) cells.
Clin Hemorheol Microcirc. 2016;61(4):667-80. doi: 10.3233/CH-152027. PubMed PMID:26639770.2016
2014 - 2015
Publications
• Rüth M, Lemke HD, Preisinger C, Krieter DH, Theelen W, Gajjala P, Devine E, Zidek W, Jankowski J,
Jankowski V.
Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites.
Acta Physiol (Oxf). 2015 Sep;215(1):13-23. doi: 10.1111/apha.12518. Epub 2015 May 19.PMID: 25939450• Krieter DH, Fink S, Dorsch O, Harenberg J, Melzer N, Wanner C, Lemke HD.
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis.
Artif Organs. 2015 Apr 20. doi: 10.1111/aor.12475. PMID: 25900127
• Desjardins L, Liabeuf S, Oliveira RB, Louvet L, Kamel S, Lemke HD, Vanholder R, Choukroun G, Massy
ZA; European Uremic Toxin (EUTox) Work Group.
Uremic toxicity and sclerostin in chronic kidney disease patients.
Nephrol Ther. 2014 Nov;10(6):463-70. doi: 10.1016/j.nephro.2014.04.002. Epub 2014 Jul 26.PMID: 25070604
• Devine E, Krieter DH, Rüth M, Jankowski J, Lemke HD.
Binding affinity and capacity for the uremic toxin indoxyl sulfate.
Toxins (Basel). 2014 Jan 24;6(2):416-29. doi: 10.3390/toxins6020416. PubMed PMID: 24469432; PubMed Central PMCID:
PMC3942743.• Krieter DH, Devine E, Wanner C, Storr M, Krause B, Lemke HD.
Clearance of Drugs for Multiple Myeloma Therapy During In Vitro High-Cutoff Hemodialysis.
Artif Organs. 2014 Jan 7. doi: 10.1111/aor.12248. PubMed PMID: 24392952.2013
Publications
• Desjardins L, Liabeuf S, Lenglet A, Lemke HD, Vanholder R, Choukroun G, Massy ZA; European Uremic
Toxin (EUTox) Work Group.
Association between free light chain levels, and disease progression and mortality in chronic kidney
disease.
Toxins (Basel). 2013 Nov 8;5(11):2058-73. doi: 10.3390/toxins5112058. PubMed PMID: 24217396; PubMed Central PMCID:
PMC3847714.• Krieter DH, Canaud B, Lemke HD, Rodriguez A, Morgenroth A, von Appen K, Dragoun GP, Wanner C.
Bisphenol A in chronic kidney disease.
Artif Organs. 2013 Mar;37(3):283-90. doi: 10.1111/j.1525-1594.2012.01556.x. Epub 2012 Nov 12. PubMed PMID: 23145999.• Janke D, Jankowski J, Rüth M, Buschmann I, Lemke HD, Jacobi D, Knaus P, Spindler E, Zidek W,
Lehmann K, Jankowski V.
The “artificial artery” as in vitro perfusion model.
PLoS One. 2013;8(3):e57227. doi: 10.1371/journal.pone.0057227. Epub 2013 Mar 7. PubMed PMID: 23505419; PubMed Central
PMCID: PMC3591414.2013
2012
Publications
• Schneider A, Drechsler C, Krane V, Krieter DH, Scharnagl H, Schneider MP, Wanner C; MINOXIS Study
Investigators.
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the
MINOXIS study.
Clin J Am Soc Nephrol. 2012 Jan;7(1):52-9. doi: 10.2215/CJN.02710311. Epub 2011 Nov 17. PubMed PMID: 22096040;• Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Diouf M, Choukroun
G, Massy ZA; European Uremic Toxin Work Group (EUTox).
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Kidney Int. 2012 Dec;82(12):1297-303. doi: 10.1038/ki.2012.301. Epub 2012 Aug 15. PubMed PMID: 22895515.• Lenglet A, Liabeuf S, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Brazier M,
Choukroun G, Massy ZA; European Uremic Toxin Work Group-EUTox.
Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease.
Int J Artif Organs. 2012 Nov;35(11):959-68. doi: 10.5301/ijao.5000124. PubMed PMID: 23065877.• Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA; European
Uremic Toxin (EUTox) Work Group.
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at
various CKD stages.
Osteoporos Int. 2012 Jul;23(7):2017-25. doi: 10.1007/s00198-011-1838-0. Epub 2011 Nov 23. PubMed PMID: 22109743.• Dorsch O, Krieter DH, Lemke HD, Fischer S, Melzer N, Sieder C, Bramlage P, Harenberg J.
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance
hemodialysis–the membrane study.
BMC Nephrol. 2012 Jun 28;13:50. doi: 10.1186/1471-2369-13-50. PubMed PMID: 22742742; PubMed Central PMCID:
PMC3508880.• Neirynck N, Eloot S, Glorieux G, Barreto DV, Barreto FC, Liabeuf S, Lenglet A, Lemke HD, Massy ZA,
Vanholder R.
Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight
uremic solutes in chronic kidney disease.
PLoS One. 2012;7(8):e44201. doi: 10.1371/journal.pone.0044201. Epub 2012 Aug 31. PubMed PMID: 22952928; PubMed Central
PMCID: PMC3432070.2001-2010
Publications
• Krieter DH, Fischer R, Merget K, Lemke HD, Morgenroth A, Canaud B, Wanner C.
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy. Nephrol Dial
Transplant.
2010 Dec;25(12):4023-31. doi: 10.1093/ndt/gfq552. Epub 2010 Oct 27. PubMed PMID: 20980359.• Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C, Choukroun G, Vanholder R,
Massy ZA; European Uremic Toxin Work Group (EUTox).
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis
patients with chronic kidney disease.
Kidney Int. 2010 Mar;77(6):550-6. doi: 10.1038/ki.2009.503. Epub 2009 Dec 16. PubMed PMID: 20016471.• Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B.
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Nephrol Dial Transplant. 2010 Jan;25(1):212-8. doi: 10.1093/ndt/gfp437. Epub 2009 Sep 15. PubMed PMID: 19755476.• Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M.
Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular
model.
Am J Nephrol. 2010;32(1):57-65. doi: 10.1159/000313452. Epub 2010 Jun 7. PubMed PMID: 20523036.
• Glorieux G, Schepers E, Schindler R, Lemke HD, Verbeke F, Dhondt A, Lameire N, Vanholder R.
A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to
the LAL-test.
Nephrol Dial Transplant. 2009 Feb;24(2):548-54. doi: 10.1093/ndt/gfn485. Epub 2008 Sep 3. PubMed PMID: 18768583.• Krieter DH, Hunn E, Morgenroth A, Lemke HD, Wanner C.
Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
Artif Organs. 2008 Dec;32(12):903-9. doi: 10.1111/j.1525-1594.2008.00652.x. PubMed PMID: 19133017.• Krieter DH, Canaud B.
New strategies in haemodialfiltration (HDF)–prospective comparative analysis between online mixed HDF
and mid-dilution HDF.
Nephrol Dial Transplant. 2008 Apr;23(4):1465-6; author reply 1466. Epub 2007 Sep 19. PubMed PMID: 17881427.• Krieter DH, Lemke HD, Wanner C.
A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein
removal.
Artif Organs. 2008 Jul;32(7):547-54. doi: 10.1111/j.1525-1594.2008.00583.x. PubMed PMID: 18638309.• Krieter DH, Morgenroth A, Barasinski A, Lemke HD, Schuster O, von Harten B, Wanner C.
Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-
weight proteins.
Nephrol Dial Transplant. 2007 Feb;22(2):491-9. Epub 2006 Oct 18. PubMed PMID: 17050637.• Krane V, Krieter DH, Olschewski M, März W, Mann JF, Ritz E, Wanner C.
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance
hemodialysis.
Am J Kidney Dis. 2007 Feb;49(2):267-75. PubMed PMID: 17261429.• Canaud B, Morena M, Cristol JP, Krieter DH.
Beta2-microglobulin, a uremic toxin with a double meaning.
Kidney Int. 2006 Apr;69(8):1297-9. PubMed PMID: 16612412.• Krieter DH, Lemke HD, Wanner C.
Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two
different biocompatible dialysis membranes.
Nephrol Dial Transplant. 2006 Feb;21(2):546; author reply 546. Epub 2005 Oct 25. PubMed PMID: 16249195.• Krieter DH, Lemke HD, Canaud B, Wanner C.
Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.
Biochim Biophys Acta. 2005 Nov 10;1753(1):146-53. Epub 2005 Aug 26. Review. PubMed PMID: 16154809.• Krieter DH, Steinke J, Kerkhoff M, Fink E, Lemke HD, Zingler C, Müller GA,
Schuff-Werner P. Contact activation in low-density lipoprotein apheresis systems.
Artif Organs. 2005 Jan;29(1):47-52. PubMed PMID: 15644083.• Krieter DH, Falkenhain S, Chalabi L, Collins G, Lemke HD, Canaud B.
Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-
dilution hemodiafiltration.
Kidney Int. 2005 Jan;67(1):349-56. PubMed PMID: 15610261.
• Krieter DH, Collins G, Summerton J, Spence E, Moragues HL, Canaud B.
Mid-dilution on-line haemodiafiltration in a standard dialyser configuration.
Nephrol Dial Transplant. 2005 Jan;20(1):155-60. Epub 2004 Nov 2. PubMed PMID: 15522903.• de Kreuk AM, Zevenbergen A, Jonuleit T, Schuurhuis GJ, Huijgens PC, Hendriks EC, van Oostveen JW,
Lemke HD, Jonkhoff AR.
Preservation of G-CSF mobilized whole blood in an automated closed hollow-fiber bioreactor system.
Cytotherapy. 2004;6(4):380-4. PubMed PMID: 16146891.• Canaud B, Lévesque R, Krieter DH, Desmeules S, Chalabi L, Moragués H, Morena M, Cristol JP.
On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode
is necessary in on-line hemodiafiltration today?
Blood Purif. 2004;22 Suppl 2:40-8. Review. PubMed PMID: 15655323.• Samtleben W, Dengler C, Reinhardt B, Nothdurft A, Lemke HD.
Comparison of the new polyethersulfone high-flux membrane DIAPES HF800 with conventional high-flux
membranes during on-line haemodiafiltration.
Nephrol Dial Transplant. 2003 Nov;18(11):2382-6. PubMed PMID: 14551370.• Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP,
Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J,
Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work
Group (EUTox).
Review on uremic toxins: classification, concentration, and interindividual variability.
Kidney Int. 2003 May;63(5):1934-43. Review. PubMed PMID: 12675874.• Krieter DH, Canaud B.
High permeability of dialysis membranes: what is the limit of albumin loss?
Nephrol Dial Transplant. 2003 Apr;18(4):651-4. PubMed PMID: 12637630.• Senécal L, Krieter DH, Moragues HL, Martin K, Canaud B.
High-flux on-line hemodiafiltration with polyethersulfone membranes: performances in hemodiafiltration
and impact of glucose administration.
Contrib Nephrol. 2003;(138):88-98. PubMed PMID: 12463150.• Tetta C, Lemke HD.
Pyrogen permeability in aqueous conditions.
Artif Organs. 2002 Dec;26(12):1063. PubMed PMID: 12460387.• Krieter DH, Canaud B.
Dialysis membranes today.
Int J Artif Organs. 2002 Aug;25(8):816. PubMed PMID: 12296468.• Morena M, Cristol JP, Senécal L, Leray-Moragues H, Krieter DH, Canaud B.
Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit?
Kidney Int Suppl. 2002 May;(80):109-14. Review. PubMed PMID: 11982824.• Krieter DH, Canaud B.
Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II
receptor antagonist.
Nephrol Dial Transplant. 2002 May;17(5):943-4. PubMed PMID: 11981096.• Lonnemann G, Sereni L, Lemke HD, Tetta C.
Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
Artif Organs. 2001 Dec;25(12):951-60. PubMed PMID: 11843762.• Gloeckner H, Lemke HD.
New miniaturized hollow-fiber bioreactor for in vivo like cell culture, cell expansion, and production of cell-
derived products.
Biotechnol Prog. 2001 Sep-Oct;17(5):828-31. PubMed PMID: 11587570.• Gloeckner H, Jonuleit T, Lemke HD.
Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue.
J Immunol Methods. 2001 Jun 1;252(1-2):131-8. PubMed PMID: 11334972.2001-2010
1991 - 2000
Publications
• Gerdemann A, Lemke HD, Nothdurft A, Heidland A, Münch G, Bahner U, Schinzel R.
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux
dialysis.
Clin Nephrol. 2000 Oct;54(4):276-83. PubMed PMID: 11076103.• Jörres A, Gahl GM, Dobis C, Polenakovic MH, Cakalaroski K, Rutkowski B, Kisielnicka E, Krieter DH,
Rumpf KW, Guenther C, Gaus W, Hoegel J.
Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal
failure: a prospective randomised multicentre trial.
International Multicentre Study Group. Lancet. 1999 Oct 16;354(9187):1337-41. PubMed PMID: 10533862.• Berner B, Krieter DH, Rumpf KW, Grunewald RW, Beuche W, Weber T, Müller GA.
Progressive multifocal leukoencephalopathy in a renal transplant patient diagnosed by JCV-specific DNA
amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial
Transplant. 1999 Feb;14(2):462-5. PubMed PMID: 10069215.• Fuchshuber A, Deltas CC, Berthold S, Stavrou C, Vollmer M, Burton C, Feest T, Krieter DH, Gal A,
Brandis M, Pierides A, Hildebrandt F.
Autosomal dominant medullary cystic kidney disease: evidence of gene locus heterogeneity.
Nephrol Dial Transplant. 1998 Aug;13(8):1955-7. PubMed PMID: 9719147.• Krieter DH, Grude M, Lemke HD, Fink E, Bönner G, Schölkens BA, Schulz E, Müller GA.
Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by
bradykinin.
Kidney Int. 1998 Apr;53(4):1026-35. PubMed PMID: 9551414.• Kaboth U, Rumpf KW, Liersch T, Vehmeyer K, Krieter DH, Kaboth W.
Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting
treatment modality for red blood cell depletion in patients with polycythemia vera.
Ther Apher. 1997 May;1(2):131-4. PubMed PMID: 10225758.• Münch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R.
Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive
ELISA.
Eur J Clin Chem Clin Biochem.1997 Sep;35(9):669-77. PubMed PMID: 9352229.• Krieter DH, Müller GA.
Cyclosporin in treatment of glomerular diseases.
Internist (Berl). 1996 Jan;37(1):84-8. Review. German. PubMed PMID: 8837833.• Krieter DH, Müller GA.
Terminal kidney insufficiency in tuberous sclerosis
Dtsch Med Wochenschr. 1995 May 19;120(20):718-22. Review. German. PubMed PMID: 7758411.• Krieter DH, Fink E, Bönner G, You HM, Eisenhauer T.
Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release. Nephrol Dial
Transplant. 1995;10(4):509-13. PubMed PMID: 7623993.• Mannstadt M, Touam M, Fink E, Ureña P, Hruby M, Zingraff J, Uhlenbusch-Körwer I, Grassmann A,
Lemke HD, Drüeke TB.
No generation of bradykinin with a new polyacrylonitrile membrane (SPAN) in haemodialysis patients
treated with ACE inhibitors.
Nephrol Dial Transplant. 1995;10(9):1696-700. PubMed PMID: 8559491.• Krieter DH, Rumpf KW, Müller GA, Werner GS.
Paradoxical cerebral embolism during fibrinolytic therapy in deep venous thrombosis of the leg and
pulmonary embolism.
Dtsch Med Wochenschr. 1994 Jun 3;119(22):825. German. PubMed PMID: 8205947.• Fink E, Lemke HD, Verresen L, Shimamoto K.
Kinin generation by hemodialysis membranes as a possible cause of anaphylactoid reactions.
Braz J Med Biol Res.1994 Aug;27(8):1975-83. PubMed PMID: 7749389.• Diamantoglou M, Lemke HD, Vienken J.
Cellulose-ester as membrane materials for hemodialysis.
Int J Artif Organs. 1994 Jul;17(7):385-91. PubMed PMID: 7806425.• Verresen L, Fink E, Lemke HD, Vanrenterghem Y.
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int.
1994 May;45(5):1497-503. PubMed PMID: 8072263.• Albanese A, Barbucci R, Belleville J, Bowry S, Eloy R, Lemke HD, Sabatini L.
In vitro biocompatibility evaluation of a heparinizable material (PUPA), based on
polyurethane and poly(amido-amine) components.
Biomaterials. 1994 Jan;15(2):129-36. PubMed PMID: 8011859.• Lemke HD.
Methods for the detection of endotoxins present during extracorporeal circulation.
Nephrol Dial Transplant. 1994;9 Suppl 2:90-5. PubMed PMID: 8065622.• Cheung AK, Lemke HD.
Criteria and standardization for biocompatibility.
Nephrol Dial Transplant. 1994;9 Suppl 2:72-6. Review. PubMed PMID: 8065619.• Lemke HD, Ward RA.
Methods for the assessment of neutrophil function duringextracorporeal circulation.
Nephrol Dial Transplant. 1994;9 Suppl 2:104-11. Review. PubMed PMID: 8065599.• Lemke HD.
Hypersensitivity reactions during haemodialysis: the choice of methods and assays.
Nephrol Dial Transplant. 1994;9 Suppl 2:120-5. Review. PubMed PMID: 7520556.• Ansorge W, Spindler E, Vienken J, Baurmeister U.
Membranes and polymer structures–biocompatibility aspects with respect to production limits. Transfus Sci.
1993 Apr;14(2):199-209. PubMed PMID: 10148613.• Norgauer J, Eberle M, Lemke HD, Aktories K.
Activation of human neutrophils by mastoparan. Reorganization of the cytoskeleton, formation of
phosphatidylinositol 3,4,5-trisphosphate, secretion up-regulation of complement receptor type 3 and
superoxide anion production are stimulated by mastoparan.
Biochem J. 1992 Mar 1;282 ( Pt 2):393-7. PubMed PMID: 1312328; PubMed Central PMCID: PMC1130791.• Norgauer J, Eberle M, Fay SP, Lemke HD, Sklar LA.
Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils.
J Immunol. 1991 Feb 1;146(3):975-80. PubMed PMID: 1988505.1981 - 1990
Publications
• Lemke HD, Heidland A, Schaefer RM.
Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide
antibodies.
Nephrol Dial Transplant. 1990;5(4):264-9. PubMed PMID: 2113222.• Floege J, Burchert W, Brandis A, Gielow P, Nonnast-Daniel B, Spindler E, Hundeshagen H, Shaldon S,
Koch KM.
Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
Kidney Int. 1990 Dec;38(6):1169-76. PubMed PMID: 2074658.• Horsch A, Martins de Sa C, Dineva B, Spindler E, Schmid HP.
Prosomes discriminate between mRNA of adenovirus-infected and uninfected HeLa cells.
FEBS Lett. 1989 Mar 27;246(1-2):131-6. PubMed PMID: 2565252.• Floege J, Nonnast-Daniel B, Gielow P, Brandis A, Spindler E, Hundeshagen H, Koch KM, Shaldon S.
Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin.
Nephron. 1989;51(3):444-7. PubMed PMID: 2645537.• Sproll MW, Spindler E, Anderer FA.
Monoclonal antibodies produced by in vitro immunization with sera of human-xenotransplant-bearing mice.
Immunol Lett. 1988 Jan;17(1):29-33. PubMed PMID: 3280477.• Lemke HD.
Mediation of hypersensitivity reactions during hemodialysis by IgE antibodies against ethylene oxide.
Artif Organs. 1987 Apr;11(2):104-10. PubMed PMID: 3297007.• Lemke HD, Kuentz F, Forêt M.
Mechanisms of hypersensitivity reactions during hemodialysis.
Trans Am Soc Artif Intern Organs. 1985;31:149-54. PubMed PMID: 3915615.• Hollmann M, Staab HJ, Spindler E, Sproll M, Anderer FA, Fortmeyer HP.
Monoclonal antibody-defined circulating human tumor-associated antigen with
epitope shared by cytokeratins.
Biochem Biophys Res Commun. 1985 Apr 16;128(1):34-9. PubMed PMID: 2580531.• Lemke HD, Bergmeyer J, Straub J, Oesterhelt D.
Reversible inhibition of the proton pump bacteriorhodopsin by modification of tyrosine 64.
J Biol Chem. 1982 Aug 25;257(16):9384-8. PubMed PMID: 6286619.• Spindler E, Stein H.
R-loop mapping of calf-thymus RNA polymerase II. Transcripts in vitro on restriction fragments of
adenovirus 2 DNA.
Eur J Biochem.1982 Jan;121(2):289-94. PubMed PMID: 6277622.• Lemke HD, Oesterhelt D.
Lysine 216 is a binding site of the retinyl moiety in bacteriorhodopsin.
FEBS Lett. 1981 Jun 15;128(2):255-60. PubMed PMID: 6790303.• Biessmann H, Kuger P, Schröpfer C, Spindler E.
Molecular cloning and preliminary characterization of a Drosophila melanogaster gene from a region
adjacent to the centromeric beta-heterochromatin.
Chromosoma. 1981;82(4):493-503. PubMed PMID: 6790248.• Lemke HD, Oesterhelt D.
The role of tyrosine residues in the function of bacteriorhodopsin. Specific nitration of tyrosine 26.
Eur J Biochem. 1981 Apr;115(3):595-604. PubMed PMID: 7016540.1981 - 1990
1976 - 1980
Publications
• Brand J, Spindler E, Stein H.
The role of basic proteins in the DNA dependent RNA polymerase reaction. Evidence that RNA
polymerase subunits are distinct from fraction S protein.
FEBS Lett. 1977 Aug 1;80(1):173-6. PubMed PMID: 891961.• Liautard JP, Setyono B, Spindler E, Köhler K.
Comparison of proteins bound to the different functional classes of messenger RNA.
Biochim Biophys Acta. 1976 Apr 2;425(4):373-83. PubMed PMID: 1259977.
To ensure that our tests meet the requirements of our customers, we have established a quality system that fulfils all the requirements of DIN EN ISO/IEC 17025:2018 and ensures the implementation of our quality policy. This makes us an accredited testing and research institute in the areas mentioned. Our accreditation is valid in around 46 countries worldwide (including the EU, the USA and Japan), as a mutual recognition agreement, known as the ILAC Arrangement, applies between the laboratory accreditation bodies of these countries.